Table 3.

Age distributions of all COVID-19 patients based on neurological diagnoses through MRI findings.

Characteristics	n = 170	Age in Years		p-Value
		Mean	SD
Severity
Yes	96	54.5	14.7	0.305
No	74	51.5	16.5
Fatality
Yes	49	55.2	15.8	0.331
No	121	52.4	15.4
Ischemic stroke
Yes	62	57.5	15.4	0.005 *
No	108	50.7	15.1
Hemorrhagic stroke
Yes	41	51.2	13.1	0.226
No	129	53.8	16.2
Encephalitis
Yes	23	48.5	13.8	0.108
No	147	53.9	15.7
Encephalopathy
Yes	11	50.3	11.8	0.406
No	159	53.4	15.8
CNS inflammation
Yes	44	53.3	15.8	0.859
No	126	53.2	15.5
Olfactory bulb enhancement
Yes	3	29.0	5.3	0.011 *
No	167	53.6	15.3
Cranial nerve enhancement
Yes	6	49.2	19.7	0.657
No	164	53.3	15.4
GBS and its variant
Yes	3	51.7	13.7	0.836
No	167	53.2	15.6
Others
Yes	6	62.3	10.3	0.147
No	164	52.9	15.6

* p-value significant at <0.05. Others include pachymeningeal enhancement and nonspecific findings such as FLAIR hyperintensities in deep white matter.